$30+ Bn ENT Devices Market – Global and Regional Analysis and Forecast, 2024-2033: Growing Preference for Minimally Invasive Procedures, Opportunities with Demand for Cosmetic ENT Procedures – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “ENT Devices Market – A Global and Regional Analysis: Focus on Product Type, End User, and Region – Analysis and Forecast, 2024-2033” report has been added to ResearchAndMarkets.com’s offering.


The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033.

The ENT devices market includes various medical tools used to diagnose, treat, and manage ear, nose, and throat conditions. This market is rapidly growing due to the increasing prevalence of ENT disorders and the demand for minimally invasive procedures. Advances in technology, including hearing aids, cochlear implants, and endoscopes, are improving patient outcomes and expanding the capabilities of ENT specialists. The market presents significant growth opportunities for healthcare providers and medical device manufacturers, driving ongoing innovation and development.

The growth of the ENT devices market has been driven by several factors, such as the rising burden of ENT disorders, growing research publications, and clinical trials in ENT devices, which have led to increased demand for ENT devices. Additionally, growing adoption and demand for minimally invasive ENT procedures have led to the development of more effective and innovative products.

Furthermore, initiatives by governments and the growing geriatric population have also played a significant role in driving market growth. Moreover, the expanding availability of these products through various distribution channels, including online platforms and retail stores, has further facilitated market expansion and accessibility to consumers worldwide.

Market Introduction

With the increasing burden of hearing loss, as mentioned by the World Health Organisation in their factsheet in February 2024, approximately 1.00 billion young adults are at risk of permanent and avoidable hearing loss owing to unsafe listening practices, and approximately 2.50 billion people are expected to have some degree of hearing loss by 2050. In addition, according to the World Federation of the Deaf, approximately 70 million people are deaf globally, and more than 80% of them are in developing countries. This has led to a surge in demand for a diverse range of ENT devices for diagnostic and surgical purposes.

With the rising prevalence of ENT disorders and the demand for minimally invasive procedures, the market has been rapidly growing. Technological advancements in devices such as hearing aids, cochlear implants, and endoscopes are improving patient outcomes and broadening the scope of ENT specialists. This growth presents new opportunities for healthcare providers and medical device manufacturers, positioning the ENT devices market for ongoing expansion.

Facilitation of its adoption in clinical practices by government approvals, reimbursement policies, and availability of OTC hearing aids has paved the way for their integration into standard ENT care. As awareness about early hearing disorder detection and its non-invasive diagnostic method continues to rise, the ENT devices market is poised for further expansion and diversification in the coming years.

Market Segmentation:

Based on product type, the ENT devices hearing aids segment players leading the market captured around 62.95% of the market’s presence as of 2023. Diagnostic devices, surgical devices, visualization devices, consumables, and others, on the other hand, accounted for approximately 3.25%, 16.95%, 9.38%, 2.29%, and 4.92% of the market presence in 2023, respectively.

Hearing Aids Segment to Dominate the ENT Devices Market (by Product Type)

The hearing aids segment is poised to dominate the ENT devices market based on product type. This dominance can be attributed to the increasing prevalence of hearing disorders such as hearing loss globally.

Hospitals Segment to Dominate the ENT Surgical Devices Market (by End User)

The hospitals segment is anticipated to dominate the ENT surgical devices market based on end users. This dominance stems from a high volume of complex surgeries being performed there. Hospital’s advanced medical infrastructure, specialized units, and skilled professionals make them the top choice for intricate ENT procedures. Additionally, the hospital’s access to a wide range of ENT surgical devices and technologies boosts surgery precision and outcomes.

Hospitals Segment to Dominate the ENT Diagnostic Devices Market (by End User)

The hospitals segment is expected to dominate the ENT diagnostic devices market based on end users. Hospitals have the necessary infrastructure, resources, and specialized medical staff to effectively use advanced ENT diagnostic devices. They also handle a high volume of complex ENT cases and serve as primary referral centers, driving the demand for these devices in hospital settings.

The North America region is positioned to hold a significant share of the global market for several compelling reasons.

The Asia-Pacific region encompasses a large and diverse population, including a significant proportion of ENT disorders-affected individuals, thereby creating a substantial market demand for ENT surgical and diagnostic devices products. The market in this region is mainly driven by technological advancements in healthcare and an increasing preference for minimally invasive ENT procedures.

Along with this rising burden of hearing loss, the growing geriatric population, leading to increasing demand for ENT devices, is leading to the growing adoption of ENT devices such as cochlear implants, hearing aids, visualization devices, diagnostic devices, surgical devices, consumables, and others.

Some prominent names established in this market are:

Ambu A/S

Boston Scientific Corporation

Cochlear Limited

Demant A/S

BEBIG Medical GmbH

Hoya Corporation

Johnson & Johnson

KARL STORZ SE & Co, KG

Medtronic plc

Olympus Corporation

Richard Wolf GmbH

Smith and Nephew plc

Sonova Holding AG

Stryker Corporation

Key Attributes:

Report Attribute
Details

No. of Pages
124

Forecast Period
2024 – 2033

Estimated Market Value (USD) in 2024
$18.19 Billion

Forecasted Market Value (USD) by 2033
$30.82 Billion

Compound Annual Growth Rate
6.0%

Regions Covered
Global

Key Topics Covered:

Executive Summary

Scope and Definition

1 Markets

1.1 Industry Outlook

1.1.1 Trends: Current and Future Impact Assessment

1.1.1.1 Miniaturization of Sensors and Components in Hearing Aids and Implants

1.1.1.2 Increasing Product Approval by Regulatory Authorities Leading to Various New Offerings in the Market

1.1.2 Patent Analysis

1.1.2.1 Patent Filing Trend (by Country)

1.1.2.2 Patent Filing Trend (by Year)

1.1.3 Regulatory Landscape

1.1.4 Supply Chain Analysis

1.1.5 Ongoing Clinical Trial Studies

1.2 Impact of COVID-19 on ENT Devices Market

1.3 Market Dynamics

1.3.1 Market Drivers

1.3.1.1 Upsurge in Prevalence of Hearing Disorders

1.3.1.2 Growing Geriatric Population Leading to Increased Demand for ENT Devices

1.3.1.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty

1.3.2 Market Restraints

1.3.2.1 High Cost of ENT Procedure

1.3.2.2 Social Stigma Associated with Hearing Disorder

1.3.3 Market Opportunities

1.3.3.1 Increasing Demand for Cosmetic ENT Procedures

2 Global ENT Devices Market, by End User

2.1 Hospitals and Ambulatory Centers

2.2 ENT Clinics

2.3 Others

3 Global ENT Devices Market, by Product Type

3.1 Diagnostic Devices

3.2 Surgical Devices

3.3 Hearing Aids

3.4 Visualization Devices

3.5 Consumables

3.6 Others

4 Region

4.1 Regional Summary

4.1.1 Regional Overview

4.1.2 Factors Driving the Market Growth

4.1.3 Factors Impeding/Limiting the Market Growth

4.1.4 By Product Type

4.1.5 By End User

4.1.6 U.S.

4.1.6.1 By Product Type

4.1.6.2 By End User

4.1.7 Canada

4.1.7.1 By Product Type

4.1.7.2 By End User

5 Markets – Competitive Benchmarking & Company Profiles

5.1 Competitive Landscape

5.1.1 Key Strategies and Development

5.1.2 Partnerships, Alliances, and Business Expansions

5.1.3 New Offerings

5.1.4 Mergers and Acquisitions

5.1.5 Regulatory and Legal Activities

5.2 Company Profiles

5.2.1 Overview

5.2.2 Top Products

5.2.3 Top Competitors

5.2.4 Target Customers/End Users

5.2.5 Analyst View

For more information about this report visit https://www.researchandmarkets.com/r/g859g2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.